Ablacon Company

Ablacon is a Wheat Ridge, Colorado-based provider of AI-guided atrial fibrillation therapies.
Technology: Big Data
Industry: AI for Longevity
Headquarters: United States
Founded Date: 2015
Investors Number: 7
Total Funding: $6.8B
Estimated Revenue: $50M to $100M
Last Funding Type: Post-IPO Equity

Visit Website
contact@ablacon.com
Register and Claim Ownership